|
|
Heath Lukatch
Chairman
Heath Lukatch has extensive healthcare venture investing experience. He joined and opened Novo Ventures’ San Francisco office in 2006, was a founding partner of SightLine Partners, and was Managing Director and Head of Biotechnology Venture Investments at Piper Jaffray Ventures. Heath has invested in multiple medical device and biotechnology companies. In addition to Inogen, Heath also serves as a Director at Synosis and NeuroTherapeutics.
Prior to his involvement in venture capital, Heath worked as a strategy consultant with McKinsey & Company, serving a range of large and small healthcare clients. Before joining McKinsey, Heath was founder and CEO of AutoMate Scientific, a San Francisco-based biotechnology instrumentation manufacturer and marketer. In addition, Heath was a bench scientist at Chiron, Cetus and Roche Bioscience in the areas of molecular biology, protein chemistry and electrophysiology, respectively.
Heath earned his Ph.D. in Neuroscience with emphasis in Pharmacology from Stanford University and his undergraduate degree with high honors in Biochemistry from the University of California at Berkeley.
|
|
|
Steve Cooper
Director
Steve Cooper is a highly accomplished, successful entrepreneur and executive with an extensive career in the semiconductor industry which began at Intel in 1973, where he held various engineering and management positions, including Engineering Manager and Wafer Fabrication Manager. From 1980 to 1987 he held various positions, including President and COO, with Silicon Systems, Inc., a manufacturer of analog/digital semiconductors; from 1987-1990 Steve served as President and CEO of Bipolar Integrated Technology, a manufacturer of bipolar emitter coupled logic semiconductors.
In 1993 Steve joined EtecSystems, Inc., a leading supplier of electron beam and laser beam mask patterning equipment for the semiconductor industry as Chairman, President and CEO. In October 1995 Steve took Etec public and in March 2000 Etec was acquired by Applied Materials for approximately $2.5 billion. Steve served as Corporate Vice President of Applied Materials and President of Etec Systems until his retirement in November 2000.
Steve currently serves as Chairman and CEO of Skyler Technologies. In addition, he also serves as Chairman of the UCSB Foundation Board of Trustees. Steve received his BSEE from the University of California at Santa Barbara.
|
|
|
William J. Link, PHD
Director
Bill Link has a proven record of building and operating large, successful medical product companies; his operating experience spans more than 23 years in general management in the healthcare industry.
One of Bill's most significant operational successes was as founder, chairman and CEO of Chiron Vision, an ophthalmic surgical products company which was sold to Bausch and Lomb in 1997 for $310 million.
Prior to entering the healthcare industry, Bill was an assistant professor in the Department of Surgery at the Indiana University School of Medicine.
Bill is currently Managing Director of Versant Ventures, which he co-founded. In addition to Inogen, Bill is a director of Cameron Health (private), AcuFocus (private) and Glaukos (private). Bill received his bachelor's, master's and doctorate degrees in mechanical engineering from Purdue University.
|
|
|
Charles Larson
Director
As a co-founder and Managing Partner of Accuitive Medical Ventures, Charlie brings over 25 years of operating experience, as well as expansive technical understanding and experience in the medical device industry. Charlie was a co-founder of Novoste Corporation where his efforts as a director and executive were critical to its ultimate success.
Charlie co-founded The Innovation Factory and serves as its Vice Chairman. Through his role at The Innovation Factory, he is co-founder of AcuFocus, LipoSonix, Cerebral Vascular Applications, NeoVista and NeuroNetics. He is the Chairman and Chief Technical Officer of OsteoLign and AqueSys and serves as the Chief Technical Officer of Cellutions. Charlie holds over 20 issued U.S. patents on medical devices. Prior to joining Novoste, Charlie held positions with Cordis Corporation and Parke-Davis in various engineering and project management roles. Charlie received a B.S. in Mechanical Engineering from the New Jersey Institute of Technology.
|
|